These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1334970

  • 21. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
    Van Harmelen V, Lönnqvist F, Thörne A, Wennlund A, Large V, Reynisdottir S, Arner P.
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
    [Abstract] [Full Text] [Related]

  • 22. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L, Rössner S, Hagström-Toft E, Reynisdottir S.
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [Abstract] [Full Text] [Related]

  • 23. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?
    Ek I, Arner P, Bergqvist A, Carlström K, Wahrenberg H.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1147-53. PubMed ID: 9100587
    [Abstract] [Full Text] [Related]

  • 24. In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis.
    Arner P, Kriegholm E, Engfeldt P.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):284-8. PubMed ID: 2164095
    [Abstract] [Full Text] [Related]

  • 25. Beta-adrenoreceptor subtype expression in human liver.
    Arner P, Engfeldt P, Hellström L, Lönnqvist F, Wahrenberg H, Sonnenfeld T, Brönnegård M.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1119-26. PubMed ID: 2172270
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome.
    Faulds G, Rydén M, Ek I, Wahrenberg H, Arner P.
    J Clin Endocrinol Metab; 2003 May; 88(5):2269-73. PubMed ID: 12727985
    [Abstract] [Full Text] [Related]

  • 27. Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
    Barbe P, Galitzky J, De Glisezinski I, Riviere D, Thalamas C, Senard JM, Crampes F, Lafontan M, Berlan M.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):619-25. PubMed ID: 9467583
    [Abstract] [Full Text] [Related]

  • 28. In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet.
    Barbe P, Stich V, Galitzky J, Kunesova M, Hainer V, Lafontan M, Berlan M.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):63-9. PubMed ID: 8989234
    [Abstract] [Full Text] [Related]

  • 29. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
    Hoffstedt J, Arner P, Hellers G, Lönnqvist F.
    J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
    [Abstract] [Full Text] [Related]

  • 30. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells.
    Rydén M, Faulds G, Hoffstedt J, Wennlund A, Arner P.
    Diabetes; 2002 May; 51(5):1601-8. PubMed ID: 11978662
    [Abstract] [Full Text] [Related]

  • 31. Effect of glucocorticosteroid treatment on beta-adrenoceptor subtype function in adipocytes from patients with asthma.
    Reynisdottir S, Wahrenberg H, Bylin G, Arner P.
    Clin Sci (Lond); 1993 Aug; 85(2):237-44. PubMed ID: 8403793
    [Abstract] [Full Text] [Related]

  • 32. Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells.
    Engfeldt P, Hellmér J, Wahrenberg H, Arner P.
    J Biol Chem; 1988 Oct 25; 263(30):15553-60. PubMed ID: 2844816
    [Abstract] [Full Text] [Related]

  • 33. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.
    Reynisdottir S, Wahrenberg H, Carlström K, Rössner S, Arner P.
    Diabetologia; 1994 Apr 25; 37(4):428-35. PubMed ID: 8063046
    [Abstract] [Full Text] [Related]

  • 34. Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients.
    Wahrenberg H, Wennlund A, Arner P.
    J Clin Endocrinol Metab; 1994 Apr 25; 78(4):898-903. PubMed ID: 8157718
    [Abstract] [Full Text] [Related]

  • 35. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
    Hoffstedt J, Shimizu M, Sjöstedt S, Lönnqvist F.
    Obes Res; 1995 Sep 25; 3(5):447-57. PubMed ID: 8521164
    [Abstract] [Full Text] [Related]

  • 36. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis.
    Rydén M, Hoffstedt J, Eriksson P, Bringman S, Arner P.
    Int J Obes Relat Metab Disord; 2001 Nov 25; 25(11):1599-603. PubMed ID: 11753577
    [Abstract] [Full Text] [Related]

  • 37. Evidence for a functional beta 3-adrenoceptor in man.
    Lönnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P.
    Br J Pharmacol; 1993 Nov 25; 110(3):929-36. PubMed ID: 7905344
    [Abstract] [Full Text] [Related]

  • 38. A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue.
    Marion-Latard F, De Glisezinski I, Crampes F, Berlan M, Galitzky J, Suljkovicova H, Riviere D, Stich V.
    Am J Physiol Regul Integr Comp Physiol; 2001 Jan 25; 280(1):R166-73. PubMed ID: 11124148
    [Abstract] [Full Text] [Related]

  • 39. Interactions between adenylate cyclase inhibitors and beta-adrenoceptors in isolated human fat cells.
    Lönnqvist F, Arner P.
    Biochem Biophys Res Commun; 1989 Jun 15; 161(2):654-60. PubMed ID: 2544167
    [Abstract] [Full Text] [Related]

  • 40. Effects of cafeteria diet feeding on beta3-adrenoceptor expression and lipolytic activity in white adipose tissue of male and female rats.
    Lladó I, Estrany ME, Rodríguez E, Amengual B, Roca P, Palou A.
    Int J Obes Relat Metab Disord; 2000 Nov 15; 24(11):1396-404. PubMed ID: 11126334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.